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As the relation between reproductive factors and breast cancer risk has not been systematically studied in indigenous women of sub-
Saharan Africa, we examined this in a case–control study in Nigeria. In-person interviews were conducted using structured
questionnaires to collect detailed reproductive history in 819 breast cancer cases and 569 community controls between 1998 and
2006. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CI). Compared with women with
menarcheal age o17 years, the adjusted OR for women with menarcheal age X17 years was 0.72 (95% CI: 0.54–0.95, P¼0.02).
Parity was negatively associated with risk (P-trend¼0.02) but age at first live birth was not significant (P¼0.16). Importantly, breast
cancer risk decreased by 7% for every 12 months of breastfeeding (P-trend¼0.005). It is worth noting that the distribution of
reproductive risk factors changed significantly from early to late birth cohorts in the direction of increasing breast cancer incidence.
Our findings also highlight the heterogeneity of breast cancer aetiology across populations, and indicate the need for further studies
among indigenous sub-Saharan women.
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Nigeria is the most populous nation in Africa with about 140
million people, and one in five Black persons all over the world has
Nigerian ancestry. Historically, Nigeria has a lower incidence rate
of breast cancer compared with the United States and other
developed countries (Parkin et al, 2005); however, the disease is
the most common malignancy seen in Nigerian women and its
incidence rate seems to be rising. Few studies have examined risk
factors for breast cancer in Nigerian women and few have
systematically examined the association with reproductive factors
in sub-Saharan Africa (Adebamowo et al, 2003a,b; Okobia et al,
2006). Early age at menarche was identified as a risk factor in one
study (Adebamowo et al, 2003b) and late age at first full-term
pregnancy was found to be significant in another study (Okobia
et al, 2006). Because modest sample sizes in these studies might
have limited the finding of associations with other reproductive
factors, we have examined a wider range of such factors on breast
cancer risk among Nigerian women in the expanded case–control
study conducted in Ibadan, Nigerian from 1998 to 2006.
MATERIALS AND METHODS
Study sample
The study setting and design are described in detail elsewhere (Huo
et al, 2007); it is an expansion of the case–control study of breast
cancer in Ibadan, Nigeria (Adebamowo et al, 2003a,b). Briefly, cases
were identified through the Surgical Oncology and Radiotherapy
units of the University College Hospital (UCH), Ibadan, which
serves a population of 3 million and is a referral centre for other
hospitals in the region. On the basis of referral patterns, the majority
of breast cancer cases in the region are probably seen at UCH. All
consecutive female cases aged 18 and above, with a histologic or
clinical diagnosis of invasive breast cancer between March 1998 and
July 2006, were eligible. Most eligible patients agreed to participate,
with a refusal rate of only 4%.
During the period of case enrolment, a community adjoining the
hospital was randomly selected by ballot from the list of all the
communities in its hypothetical catchment area and considered to
be stable, socio-economically diverse, and represents the diversity
of UCH patients. Names were then randomly selected from the
community register and the individuals were invited to visit a
clinic setup in the community for the study. Inclusion criteria for
the controls were female, aged 18 years or older, absence of any
type of cancer, and ability to give informed consent.
Data collection and measurements
The study was approved by the Institutional Review Boards of
the University of Chicago and the University of Ibadan. After
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tered a structured questionnaire, measured height and weight, and
obtained blood samples. The questionnaire covered demographic
characteristics, family history of breast cancer and history of
benign breast disease, lifestyle factors, menstrual and reproductive
history, and hormonal contraceptive use.
We examined four reproductive factors in relation to breast
cancer risk which are as follows: age at menarche, parity, age at
first live birth, and duration of breastfeeding. Ages at menarche
and parity were each considered in four categories: 10–14, 15–16,
17–18, and 418 years old and 0, 1–3, 4–6, and X7 live births,
respectively. Age at first live birth was grouped into four: o20,
20–24, 25–29, and 30 or older; lifetime duration of breastfeeding
into five categories: p24, 25–48, 49–72, 73–96, and 496 months.
Since lifetime duration of breastfeeding tends to be longer as parity
increases, mean duration of breastfeeding per child was calculated
as total duration divided by parity for parous women, and it was
dichotomised as o 12 and X12 months.
On the basis of current literature, we considered the following as
potential confounders and categorised as appropriate for further
analysis using logistic regressions: age at diagnosis or interview (5-
year interval categories), ethnicity (Yoruba, others), education
(none, elementary, secondary, vocational, and some college or
above), family history of breast cancer (yes, no), benign breast
disease (yes, no), hormonal contraceptive use (ever, never),
alcohol drinking (yes, no), height, body mass index (BMI), and
menopausal status (premenopausal, natural postmenopausal,
artificial postmenopausal). Alcohol drinking was defined as
consumption of alcoholic beverages at least once a week for 6
months or longer.
Statistical analyses
Demographic factors and potential confounding variables were
compared between cases and controls using t-tests or Wilcoxon
rank-sum tests for continuous variables and w
2 tests for categorical
data. Logistic regression models were used to examine the
relationship of breast cancer risk with reproductive factors. Odds
ratio (OR) and 95% confidence intervals (CI) were computed as
measures of association from the logistic models. Multiple logistic
regression models were used to adjust for age and other potential
confounders listed above. We also tested whether the effects of
reproductive factors varied according to menopausal status by
adding an interaction term in the logistic models. All five
reproductive factors were included as both continuous and
categorical variables in the models. Parity was further modelled
using a linear spline function with a knot at one live birth to assess
the effect of first live birth and trend after the first live birth,
simultaneously (Greenland, 1998). Finally, linear regression or
Wilcoxon rank-sum test was used to examine the secular trend of
reproductive factors according to birth cohort of controls.
Kaplan–Meier survival analysis was conducted to estimate the
proportion having first baby at a specified age. All P-values
reported are two-sided.
About 8% of participants had a missing value for age at
menarche. Data were occasionally missing for other variables as
well. To use all available information and avoid bias due to listwise
deletion in the multivariate analysis, missing values were imputed
20 times via the method of multiple imputation by chained
equations (van Buuren et al, 1999). Standard errors of regression
coefficients were determined using a general formula for combin-
ing estimates in multiple imputation, which assumes that data are
missing at random (Rubin, 1987). Older women tended to forget
their menarcheal age. After including age in the multiple
imputation models, it is reasonable to believe that the probability
of missing menarcheal age is unrelated to the value itself. All
statistical analyses were conducted with Stata 9.2 (StataCorp,
College Station, TX, USA). Multiple imputation was conducted
using the ice module (Royston, 2004).
RESULTS
There were 1388 women in this study: 819 cases and 569 controls.
Table 1 shows the demographic characteristics and nonreproduc-
tive factors in cases and controls. On average, cases were 5 years
older than controls. Most participants were Yoruba (more so
among the controls), the dominant group in Southwestern Nigeria,
but there were also some Hausa and Ibo. Cases and controls were
similar in hormonal contraceptive use, years of education, and
BMI. Compared with controls, cases were more likely to have a
family history of breast cancer, a history of benign breast disease,
and to have consumed alcohol. More cases were postmenopausal
women than controls were. Finally, cases were 1.7cm, on average,
taller than controls. All these variables were considered to be
potential confounders and were adjusted in subsequent analyses.
Table 2 presents the distribution of reproductive factors for
cases and controls. The majority of women had their menarche at
or after age 15, and it was inversely associated with breast cancer
risk (P¼0.001). In the age-adjusted analysis, women with
menarche at or after age 17 years showed about 40% lower risk
than those with menarche at less than 17 years. Cases were more
Table 1 Selected characteristics of cases with invasive breast cancer and
community controls, Nigeria, 1998–2006
Characteristic
Cases
(n¼819)
Controls
(n¼569) P-value
Age in years, mean±s.d. 46.8±11.3 41.2±13.8 o0.001
Ethnicity, n (%)
Yoruba 609 (74.4) 537 (94.4) o0.001
Ibo 89 (10.9) 12 (2.1)
Hausa 14 (1.7) 1 (0.2)
Others 107 (13.1) 19 (3.3)
Education, n (%) 0.13
No formal 191 (23.3) 112 (19.7)
Elementary 197 (24.1) 106 (18.6)
Secondary 131 (16.0) 160 (28.1)
Vocational 123 (15.0) 63 (11.1)
Some college or above 177 (21.6) 128 (22.5)
Family history of breast cancer, n (%)
Yes 69 (8.4) 27 (4.7) 0.01
No 750 (91.6) 542 (95.3)
Benign breast disease, n (%)
Yes 141 (17.2) 71 (12.5) 0.02
No 678 (82.8) 498 (87.5)
Menopausal status, n (%) o0.001
Premenopausal 463 (56.5) 404 (71.0)
Postmenopausal, natural 339 (41.4) 161 (28.3)
Postmenopausal, artificial 17 (2.1) 4 (0.7)
Age at natural menopause,
mean±s.d.
48.2±5.7 49.9±5.5 0.002
Hormonal contraceptives, n (%)
Yes 198 (24.2) 125 (22.0) 0.37
No 621 (75.8) 444 (78.0)
Alcohol drink, n (%)
Yes 107 (13.1) 43 (7.6) 0.001
No 708 (86.9) 526 (92.4)
Height in cm, mean±s.d. 160.2±6.8 158.5±6.6 o0.001
BMI in kgm
 2, mean±s.d. 25.4±5.4 25.2±5.5 0.65
Abbreviations: BMI¼body mass index; s.d.¼standard deviation.
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trend between parity and risk (P¼0.02). In the spline regression,
the age-adjusted OR was 0.69 (95% CI: 0.43–1.09) for the first live
birth and 0.97 (95% CI: 0.91–1.03) for each later additional birth.
No significant difference was found between cases and controls
with regard to age at first live birth. All but four parous women
(0.3%) had breastfed their babies. The lifetime duration of
breastfeeding was quite long, averaging 66 months (range: 1–294
months) with overall, only 1.4% for less than 6 months. There was
a dose–response relationship between lifetime duration and risk
(P¼0.005). Mean duration of breastfeeding per child was also
negatively associated with risk (P¼0.007). Women who had
breastfed at least 12 months per child had their risk decreased by
one-third.
Overall, there were 220 (1.1%) missing values of 14 variables in
Tables 1 and 2 (excluding derivative variables) distributed among
151 women (10.9%, 119 cases, and 32 controls). One hundred and
five (7.6%) had missing age at menarche, particularly among older
women: the mean age was 43.9 and 52.6 years, respectively, for
women who remembered and those who forgot menarcheal age
(Po0.001). Women with missing data were included in the
multivariate analysis to avoid unnecessary loss of power and
potential bias. Twenty data sets were generated by multiple
imputation such that the efficiency of estimating OR was greater
than 99.5% for the fraction of missing information up to 0.08.
Table 3 shows multivariate-adjusted ORs for reproductive
factors using data after multiple imputation. After adjustment
for parity, age at first live birth, breastfeeding, and other potential
confounders, the association between age at menarche and risk
was attenuated but still statistically significant. The adjusted OR
was 0.72 (95% CI: 0.54–0.95, P¼0.02) for menarche at or after age
17 years, compared with age less than 17 years. In the multivariate
analysis, there was still an inversed association between parity and
risk (P¼0.02). In the spline regression, the multivariate-adjusted
OR was 0.81 (95% CI: 0.49–1.34) for the first live birth and 0.95
(95% CI: 0.88–1.02) for each additional birth. Since there was a
strong correlation between lifetime duration of breastfeeding and
parity (r¼0.83, Po0.001), the association between multiparity (in
parous women) and risk was further examined after adjusting for
Table 2 Reproductive factors and breast cancer, Nigeria, 1998–2006
No. of
cases
No. of
controls
Age-adjusted OR
(95% CI)
Age at menarche (years)
10–14 265 181 1.0 (ref.)
15–16 300 203 0.90 (0.68–1.20)
17–18 123 120 0.60 (0.43–0.83)
X19 47 44 0.56 (0.35–0.91)
P-value for trend 0.001
Mean±s.d. 15.2±2.1 15.4±2.3
Per 2-year delay 0.86 (0.77–0.96)
Parity
0 74 103 1.0 (ref.)
1–3 247 175 0.70 (0.45–1.11)
4–6 361 207 0.55 (0.34–0.89)
X7 135 74 0.52 (0.30–0.89)
P-value for trend 0.02
Mean±s.d. 4.2±2.5 3.5±2.6
First live birth 0.69 (0.43–1.09)
Each additional live birth 0.97 (0.91–1.03)
Age at first live birth (years)
a
o20 166 84 1.0 (ref.)
20–24 325 206 0.75 (0.54–1.04)
25–29 181 132 0.70 (0.49–1.00)
X30 66 32 0.94 (0.57–1.57)
P-value for trend 0.40
Mean±s.d. 22.9±4.7 23.2±4.1
Per 5-year increase 0.93 (0.81–1.07)
Lifetime duration of breastfeeding (months)
a
p24 130 82 1.0 (ref.)
25–48 198 115 0.82 (0.56–1.21)
49–72 147 100 0.59 (0.39–0.90)
73–96 125 71 0.63 (0.40–0.99)
4 96 142 88 0.54 (0.34–0.85)
P-value for trend 0.005
Mean±s.d. 66±44 65±44
Per 12-month increase 0.96 (0.92–0.99)
Mean duration of breastfeeding per child (months)
a
o12 234 113 1.0 (ref.)
X12 509 343 0.68 (0.52–0.90)
P-value 0.007
Abbreviations: CI¼confidence interval; OR¼odds ratio; s.d.¼standard deviation.
aAmong parous women.
Table 3 Multiple logistic regression analysis using data after multiple
imputation on the relationship between reproductive factors and breast
cancer, Nigeria, 1998–2006
OR (95% CI)
a OR (95% CI)
Age at menarche (years)
10–14 1.0 (ref.) 1.0 (ref.)
b
15–16 0.99 (0.73–1.34) 1.00 (0.73–1.35)
17–18 0.71 (0.49–1.02) 0.71 (0.50–1.03)
X19 0.68 (0.41–1.14) 0.71 (0.42–1.20)
P-value for trend 0.03 0.04
Per 2-year delay 0.90 (0.80–1.02) 0.92 (0.81–1.03)
b
Parity
0 1.0 (ref.) 1.0 (ref.)
c
1–3 0.78 (0.48–1.27) 0.79 (0.48–1.29)
4–6 0.63 (0.38–1.06) 0.63 (0.37–1.06)
X7 0.51 (0.28–0.93) 0.52 (0.28–0.94)
P-value for trend 0.02 0.02
First live birth 0.80 (0.49–1.32) 0.81 (0.49–1.34)
c
Each additional live birth 0.95 (0.88–1.02) 0.95 (0.88–1.02)
c
Age at first live birth in parous women (years)
o20 1.0 (ref.) 1.0 (ref.)
d
20–24 0.88 (0.62–1.26) 0.87 (0.60–1.25)
25–29 0.73 (0.48–1.09) 0.66 (0.43–1.02)
X30 0.90 (0.51–1.58) 0.80 (0.44–1.47)
P-value for trend 0.32 0.16
Per 5-year increase 0.92 (0.78–1.08) 0.87 (0.73–1.04)
d
Lifetime duration of breastfeeding in parous women (months)
p24 1.0 (ref.) 1.0 (ref.)
e
25–48 0.94 (0.62–1.43) 0.83 (0.54–1.30)
49–72 0.66 (0.42–1.05) 0.52 (0.31–0.89)
73–96 0.73 (0.44–1.20) 0.53 (0.28–0.98)
496 0.57 (0.34–0.95) 0.36 (0.17–0.75)
P-value for trend 0.02 0.005
Per 12-month increase 0.96 (0.92–1.00) 0.93 (0.87–1.00)
e
Mean duration of breastfeeding per child in parous women (months)
o12 1.0 (ref.) 1.0 (ref.)
f
X12 0.75 (0.56–1.02) 0.74 (0.55–1.01)
P-value 0.07 0.06
Abbreviations: CI¼confidence interval; OR¼odds ratio; s.d.¼standard deviation.
aAdjusted for age, ethnicity, education, family history of breast cancer, benign breast
disease, hormonal contraceptive use, alcohol drinking, height, body mass index, and
menopausal status.
bAdditionally adjusted for parity, age at first live birth, and duration
of breastfeeding.
cAdditionally adjusted for age at menarche.
dAdditionally adjusted
for age at menarche, parity, and duration of breastfeeding.
eAdditionally adjusted for
age at menarche, parity, and age at first live birth.
fAdditionally adjusted for age at
menarche and age at first live birth.
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with OR¼1.04 (95% CI: 0.93–1.15, P¼0.49) for each additional
birth beyond the first. Conversely, the association between breast
cancer and lifetime duration of breastfeeding persisted after
adjustment for parity, age at first live birth, and other potential
confounders (7% decline in OR for each 12 months breastfeeding;
P¼0.005). Similarly, mean duration of breastfeeding per child was
negatively associated with risk: women who had breastfed at least
12 months per child had one-quarter decreased risk (P¼0.06). Age
at first live birth remained nonsignificant in the multivariate
analyses. We also tested whether the effect of these reproductive
factors varied by menopausal status and found no significant
interaction between these factors and menopausal status (data not
shown).
To examine how the prevalence of reproductive factors changed
for women born in earlier and later decades, we grouped healthy
controls into five birth cohorts as shown in Table 4. The average
age at menarche decreased over time from 54% before age 17 years
for women born before 1940, compared with 77% for those born
after 1970. The numbers of pregnancies and live births were also
significantly decreased over time among all women or those 40
years or older at interview. Because almost all babies (95%) were
born to women younger than age 40, the number of live births in
women 40 years or older represent their lifetime parity and
younger women might not have reached their full potential for
reproduction. The mean age at first live birth did not change
substantially over time for parous women but there are more
nulliparous women in the recent birth cohort. Taking into account
nulliparous women who have not had their first baby by age 25, the
proportion having their first baby before age 25 was significantly
decreased from 73% in the oldest cohort to 36% in the youngest
cohort. The lifetime duration of breastfeeding decreased markedly
over time, partly due to smaller family size and partly due to
shorter duration of breastfeeding per child. On the basis of ORs in
Table 3 and the secular trend of the reproductive factors in Table 4
(excluding the youngest birth cohort), we estimated the contribu-
tion to the change in breast cancer incidence. Breast cancer
incidence was estimated to have increased 7% due to change in
menarcheal age, 15% due to decreased parity, and 15% due to
shortened duration of breastfeeding per child.
DISCUSSION
This study demonstrates that reproductive factors play an
important role in breast cancer aetiology among indigenous
African women. We found that ages at menarche, parity, and
breastfeeding were significant predictors, although their distribu-
tions in our population were quite different from those in
industrialised countries. We did not find that early age at first
live birth was associated with decreased risk of breast cancer after
extensive statistical adjustment.
Later age at menarche has been consistently associated with
decreased risk of breast cancer in both premenopausal and
postmenopausal women (Kelsey et al, 1993; Clavel-Chapelon and
Gerber, 2002). In the current study, a delay of 2 years in menarche
corresponds to a 7% reduction in risk, which is in line with the
10% reduction observed in an international multicentre study
(Hsieh et al, 1990).
Parous women have a lower risk than nulliparous women, but
the relationship between parity and breast cancer is complex
(Kelsey et al, 1993; Colditz et al, 2006). Risk initially increases after
the first pregnancy, then decreases after 10–15 years (Lambe et al,
1994). We observed the long-term protective effect, with 19% risk
reduction for the first birth, but not the transient increase after the
first birth, perhaps because on the modified Pike model, this was
shorter for multiparous women (Rosner et al, 1994) about 80% of
participants and were multiparous.
There is controversy over whether the number of full-term
pregnancies beyond the first is protective (Kelsey et al, 1993).
According to the collaborative reanalysis of 47 epidemiologic
studies, each birth reduces the relative risk of breast cancer by 7%
in the absence of breastfeeding and each child breastfed
corresponds to a 3.4% decreased risk, but the association with
parity was not significant after stratification by lifetime duration of
breastfeeding (Collaborative Group on Hormonal Factors in Breast
Cancer, 2002). Similarly, we found risk decreased by 5% per each
additional birth after the first birth and by 7% per 12 months of
breastfeeding. The beneficial effect of breastfeeding was indepen-
dent of multiparity but multiparity was not an independent factor.
We did not find significant association between age at first live
birth and risk, which seems inconsistent with all the evidence from
Table 4 Reproductive factors by birth cohort in healthy controls, Nigeria, 1998–2006
o1940
(n¼46)
1940–1949
(n¼75)
1950–1959
(n¼117)
1960–1969
(n¼145)
X1970
(n¼186) P-value
Age at menarche (years), n (%)
o17 22 (53.7) 42 (59.2) 73 (66.4) 106 (74.6) 141 (76.6) o0.001
X17 19 (46.3) 29 (40.8) 37 (33.6) 36 (25.4) 43 (23.4)
Mean±s.d. 16.4±2.6 16.2±2.5 15.6±2.4 15.1±2.2 15.0±2.1 o0.001
No. of pregnancy, mean±s.d.
In all women 7.0±2.8 6.5±1.9 5.6±1.9 4.2±2.0 1.4±1.6 o0.001
In women X40 years old 7.0±2.8 6.5±1.9 5.6±1.9 4.6±2.1 — o0.001
Parity, mean±s.d.
In all women 6.1±2.5 5.8±1.8 5.0±1.9 3.5±1.7 1.0±1.2 o0.001
In women X40 years old 6.1±2.5 5.8±1.8 5.0±1.9 4.0±1.7 — o0.001
Age at first live birth (years)
o25, % 72.7 63.0 66.7 56.7 35.6
a o0.001
Mean±s.d. 22.3±4.0 23.4±3.7 22.7±4.1 23.8±4.4 23.4±3.9 0.11
Lifetime duration of breastfeeding (months), mean±s.d.
In all women 117±61 88±43 71±35 56±30 27±17 o0.001
In women X40 years age 117±61 88±43 71±35 64±34 — o0.001
Mean duration of breastfeeding per child (months),
mean±s.d.
18.8±7.5 15.1±6.7 13.8±4.5 14.5±4.1 13.6±4.7 o0.001
Abbreviation: s.d.¼standard deviation.
aCalculated from Kaplan–Meier analysis, which took into account women younger than 25 years.
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ystudies mainly in Caucasian and Asian populations (Kelsey et al,
1993; Clavel-Chapelon and Gerber, 2002). Risk factors may vary by
breast cancer subtypes, as it is a heterogeneous disease, varying in
different populations. A recent meta-analysis showed that the age
at first birth was associated only with ERþPRþ breast cancer but
not with ER PR  breast cancer (Ma et al, 2006). In addition, a
large population-based study in the United States showed that
ERþ or PRþ breast tumours are the majority, although propor-
tions varied by race/ethnicity: the highest in non-Hispanic White
or Asian Americans and Pacific Islanders, followed by Hispanics,
and the lowest in African Americans (Chu and Anderson, 2002). In
contrast, two studies in Nigeria (Ikpatt and Ndoma-Egba, 2003;
Gukas et al, 2005) and a collaborative study in West Africa (OI
Olopade et al, unpublished data) found that only about 25% of
tumours were ERþ, though a recent study in Nigeria found that
65% were ERþ (Adebamowo et al, 2007). Therefore, the lack of associ-
ation between age at first live birth and breast cancer risk may be
due to heterogeneity of tumour subtypes in our study sample.
The current study documented that 30% of Nigerian women
started menarche after age 16, the majority had multiple live
births, they almost always breastfed their babies, more than half
for 12 months or longer per child. These factors probably
contribute to the low incidence of breast cancer in Nigerian
women. However, these protective effects may be diminishing as
women adopt a more western lifestyle. In community controls,
their patterns should show similar changes to those in the general
population. We found that all reproductive factors changed in the
direction towards increased breast cancer risk. We estimated that
risk increased by about 37% in women born in 1960s compared to
those born in 1930s, due to change in menarcheal age, parity, and
duration of breastfeeding. Therefore, incidence in Nigerian
population might have increased in the past three decades, and
we speculate that it will continue as women born after 1960s
become older. A systematic study of the secular trend of incidence
in Nigeria is of public health importance.
Several limitations are relevant. First, reproductive history was
self-reported and may be subject to recall bias. Women can reliably
report the number of children they have had, so differential
reporting of parity is probably not a serious problem. Duration of
breastfeeding, age at menarche, and age at first live birth are less
accurate, but presumably not differentially recalled by cases and
controls. Second, although the multiple imputation method was
employed reasonably to address the missing age at menarche,
additional ‘measurement error’ is unavoidable. Third, the estimated
trend of breast cancer incidence in Nigeria may have limited
accuracy because it is based on the reproductive histories of women
from a single community, relative risks from this single study, and
the assumption that the population structure is constant over time.
Our study population provides an important opportunity to
elucidate the effect of reproductive risk factors on risk in
prevalence ranges that are not seen in the developed world. A
live birth, extended breastfeeding, and later onset of menstruation
are protective in Nigerian women, but we found no independent
effect of age at first live birth. The study also documents the
changing pattern in reproductive factors, which could explain the
generally low incidence of breast cancer in Nigerian women and
suggests that this may increase over time.
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